Research Output per year
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 60 Similar Profiles
Rheumatoid Arthritis
Medicine & Life Sciences
Psychometrics
Medicine & Life Sciences
ametantrone
Medicine & Life Sciences
Health
Medicine & Life Sciences
Fibromyalgia
Medicine & Life Sciences
Reproducibility of Results
Medicine & Life Sciences
Joints
Medicine & Life Sciences
Mindfulness
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2005 2019
Advocacy for use of the modified Iowa Level of Assistance Scale for clinical use in patients after hip replacement: an observational study
Elings, J., Zoethout, S., ten Klooster, P. M., van der Sluis, G., van Gaalen, S., van Meeteren, N. L. U. & Hoogeboom, T. J., Mar 2019, In : Physiotherapy. 105, 1, p. 108–113Research output: Contribution to journal › Article › Academic › peer-review
Open Access
File
Observational Studies
Hip
Hospitalization
Hip Replacement Arthroplasties
Physical Therapists
De kwaliteit van de therapeutische relatie voorspelt uitkomst van psychotherapie bij depressie
Reefhuis, E. R., van Dijk, M. K., Miggiels, M. F., ten Klooster, P. M., Huibers, M. J. H. & Dekker, J. J. M., 2019, In : Tijdschrift voor psychotherapie. 45, 1, p. 6-23Research output: Contribution to journal › Article › Academic
Development and preliminary evaluation of a short self-report measure of generalized pain hypersensitivity
van Bemmel, P. F., Oude Voshaar, M. A. H., ten Klooster, P. M., Vonkeman, H. E. & van de Laar, M. A. F. J., 17 Jan 2019, In : Journal of pain research. 12, p. 395-404Research output: Contribution to journal › Article › Academic › peer-review
Open Access
File
Self Report
Hypersensitivity
Pain
Fibromyalgia
Neuralgia
Fibromyalgia: increased reactivity of the muscle membrane and a role of central regulation
Klaver-Krol, E. G., Rasker, J. J., Klaver, M., ten Klooster, P. M. & Zwarts, M. J., 1 Jan 2019, In : Clinical neurophysiology. 130, 1, p. 12-19 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Fibromyalgia
Muscles
Membranes
Extremities
Statistical Distributions
An economic evaluation of stopping versus continuing TNF-inhibitor treatment in rheumatoid arthritis patients in remission or low disease activity: results from the POET randomized trial
Tran-Duy, A., Ghiti Moghadam, M., Oude Voshaar, M. A. H., Vonkeman, H. E., Boonen, A., Philip, C., McColl, G., ten Klooster, P. M., Zijlstra, T., Lems, W. F., Riyazi, N., Griep, E. N., Hazes, M., Landewe, R., Bernelot Moens, H. J., van Riel, P. L. C. M., van de Laar, M. A. F. J. & Jansen, T. L., Oct 2018, In : Arthritis & rheumatology. 70, 10, p. 1557-1564 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Quality-Adjusted Life Years
Cost-Benefit Analysis
Rheumatoid Arthritis
Costs and Cost Analysis
Tumor Necrosis Factor-alpha
Activities 2014 2018
PLoS ONE (Journal)
Peter M. ten Klooster (Editor)9 Apr 2018 → …
Activity: Publication peer-review and editorial work › Editorial work
COTAN - Commissie Testaangelegenheden van het Nederlands Instituut van Psychologen (External organisation)
Peter M. ten Klooster (Chair)2 May 2016 → …
Activity: Membership › Membership of committee
Measuring values and committed action: The Engaged Living Scale.
H.R. Trompetter (Speaker), Ernst Thomas Bohlmeijer (Speaker), Peter M. ten Klooster (Speaker), P. Knirsch (Speaker), Karlein Maria Gertrudis Schreurs (Speaker)17 Jul 2015
Activity: Talk or presentation › Oral presentation
Predicting non-improved subjective health in rheumatiod arthritis patients with a clinical response to biologic treatment
Antonius H. Oude Voshaar (Speaker), Erik Taal (Speaker), Peter M. ten Klooster (Speaker), Harald Erwin Vonkeman (Speaker), Mart A F J van de Laar (Speaker)6 Feb 2014
Activity: Talk or presentation › Oral presentation
Predicting non-improved subjective health in rheumatiod arthritis patients with a clinical response to biologic treatment
Erik Taal (Speaker), Antonius H. Oude Voshaar (Speaker), Peter M. ten Klooster (Speaker), Harald Erwin Vonkeman (Speaker), Mart A F J van de Laar (Speaker)20 Aug 2014
Activity: Talk or presentation › Oral presentation